First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease

The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). However, poor adherence to the standardized regimens recommended by current guidelines have been reported. We undertook a sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Kiyoharu, Kitada, Seigo, Komukai, Sho, Kuge, Tomoki, Matsuki, Takanori, Kagawa, Hiroyuki, Tsujino, Kazuyuki, Miki, Mari, Miki, Keisuke, Kida, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807086/
https://www.ncbi.nlm.nih.gov/pubmed/33441977
http://dx.doi.org/10.1038/s41598-021-81025-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807086/
https://www.ncbi.nlm.nih.gov/pubmed/33441977
http://dx.doi.org/10.1038/s41598-021-81025-w

Ejemplares similares